About James Eadie
James Eadie is a managing director at Santé and an Endogenex board member. Endogenex is developing an investigational endoscopic system that applies pulsed electric fields in the duodenum for type 2 diabetes. He also serves on Reprieve Cardiovascular's board, which develops automated fluid-management technology for heart failure.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name James Eadie in the role, so the role may have started earlier or lasted longer.
Endogenex, Inc. Current
Managing Director
2018 – Present · Plymouth, MN
Endogenex develops an outpatient endoscopic system using pulsed electric fields to treat duodenal tissue in adults with type 2 diabetes.
SA
Santé Current
Managing Director
Key Colleagues at Startups
The people James Eadie works with at each company, as listed on that company's latest Form D.
Endogenex, Inc. · Form D/A, Nov 6, 2026
Stacey Pugh
CEO and director
Juliet Bakker
Co-Founder and Managing Director
GB
Gerald Brunk
Managing Director
DR
Doug Reed
Director
TS
Thomas Shehab
Managing Partner and director
CryOSA, Inc. · Form D, Aug 1, 2025
DF
Doug French
Director
DG
Donald Gonzales
Director
DB
David Belitz
Director
LS
Laura Stoltenberg
Chief Executive Officer and director
Reprieve Cardiovascular, Inc. · Form D, Jun 5, 2025
JG
Jan Garfinkle
Director
TF
Tony Fields
Executive officer
Mark Pacyna
Chief Executive Officer and director
EB
Ethan Benovitz
Director
HI
Hanson Gifford III
Director
AB
Adam Bartnik
Executive officer
DN
David Neustaedter
Director